42 related articles for article (PubMed ID: 10084263)
1. Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells.
Goldman A; Raschi E; Chapman J; Santomasso BD; Pasquini MC; Perales MA; Shouval R
Blood; 2023 Feb; 141(6):673-677. PubMed ID: 36332168
[TBL] [Abstract][Full Text] [Related]
2. Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option.
Ripellino P; Comi C; Mula M; Varrasi C; Conconi A; Stecco A; Brustia D; Nasuelli N; Savio K; De Paoli L; Cantello R; Gaidano G; Monaco F
BMJ Case Rep; 2011 Apr; 2011():. PubMed ID: 22701032
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome of progressive multifocal leukoencephalopathy with recombinant interleukin-2 treatment and an associated increase in the number of HPyV-2-specific T-cells: a case report.
Hoff FW; Rolwes J; Hardeman PA; Perkins M; Major EO; Douek D; Collins RH; Greenberg BM
Ther Adv Hematol; 2023; 14():20406207231201721. PubMed ID: 37822572
[TBL] [Abstract][Full Text] [Related]
4. Progressive multifocal leukoencephalopathy in multiple myeloma. A literature review and lessons to learn.
Koutsavlis I
Ann Hematol; 2021 Jan; 100(1):1-10. PubMed ID: 33009935
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient.
Oza A; Rettig MP; Powell P; O'Brien K; Clifford DB; Ritchey J; Gehrs L; Hollaway J; Major E; Fehniger TA; Miller CA; Soon-Shiong P; Rock A; DiPersio JF
Blood Adv; 2020 Jun; 4(11):2387-2391. PubMed ID: 32484854
[TBL] [Abstract][Full Text] [Related]
6. Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.
Maas RP; Muller-Hansma AH; Esselink RA; Murk JL; Warnke C; Killestein J; Wattjes MP
J Neurol; 2016 Oct; 263(10):2004-21. PubMed ID: 27401179
[TBL] [Abstract][Full Text] [Related]
7. Detection of cases of progressive multifocal leukoencephalopathy associated with new biologicals and targeted cancer therapies from the FDA's adverse event reporting system.
Raisch DW; Rafi JA; Chen C; Bennett CL
Expert Opin Drug Saf; 2016 Aug; 15(8):1003-11. PubMed ID: 27268272
[TBL] [Abstract][Full Text] [Related]
8. Progressive multifocal leukoencephalopathy: current treatment options and future perspectives.
Pavlovic D; Patera AC; Nyberg F; Gerber M; Liu M;
Ther Adv Neurol Disord; 2015 Nov; 8(6):255-73. PubMed ID: 26600871
[TBL] [Abstract][Full Text] [Related]
9. Smoldering myeloma presenting as progressive multifocal leukoencephalopathy: a case report.
Troppmann M; Büttner R; Boewer M; Salzberger B
J Med Case Rep; 2012 Jul; 6():177. PubMed ID: 22747665
[TBL] [Abstract][Full Text] [Related]
10. Progressive multifocal leukoencephalopathy in transplant recipients.
Mateen FJ; Muralidharan R; Carone M; van de Beek D; Harrison DM; Aksamit AJ; Gould MS; Clifford DB; Nath A
Ann Neurol; 2011 Aug; 70(2):305-22. PubMed ID: 21823157
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy and natalizumab.
Hellwig K; Gold R
J Neurol; 2011 Nov; 258(11):1920-8. PubMed ID: 21647730
[TBL] [Abstract][Full Text] [Related]
12. Progressive multifocal leukoencephalopathy and other forms of JC virus disease.
Brew BJ; Davies NW; Cinque P; Clifford DB; Nath A
Nat Rev Neurol; 2010 Dec; 6(12):667-79. PubMed ID: 21131916
[TBL] [Abstract][Full Text] [Related]
13. Case files of the New York City poison control center: paradichlorobenzene-induced leukoencephalopathy.
Hernandez SH; Wiener SW; Smith SW
J Med Toxicol; 2010 Jun; 6(2):217-29. PubMed ID: 20373064
[No Abstract] [Full Text] [Related]
14. Detection and typing of BKV, JCV, and SV40 by multiplex nested polymerase chain reaction.
Bergallo M; Costa C; Margio S; Sidoti F; Segoloni GP; Ponzi AN; Cavallo R
Mol Biotechnol; 2007 Mar; 35(3):243-52. PubMed ID: 17652788
[TBL] [Abstract][Full Text] [Related]
15. Identical rearranged forms of JC polyomavirus transcriptional control region in plasma and cerebrospinal fluid of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy.
Fedele CG; Ciardi MR; Delia S; Contreras G; Perez JL; De Oña M; Vidal E; Tenorio A
J Neurovirol; 2003 Oct; 9(5):551-8. PubMed ID: 13129769
[TBL] [Abstract][Full Text] [Related]
16. Progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy.
Re D; Bamborschke S; Feiden W; Schröder R; Lehrke R; Diehl V; Tesch H
Bone Marrow Transplant; 1999 Feb; 23(3):295-8. PubMed ID: 10084263
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
18. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
Wang EH; Chen YA; Corringham S; Bashey A; Holman P; Ball ED; Carrier E
Bone Marrow Transplant; 2004 Oct; 34(7):581-7. PubMed ID: 15273714
[TBL] [Abstract][Full Text] [Related]
19. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
